Saksenaea vasiformis Orbital Cellulitis in an Immunocompetent Child Treated With Posaconazole

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e169-e171. doi: 10.1093/jpids/piy021.

Abstract

An 11-year-old immunocompetent girl presented with two and a half months of progressive right orbital cellulitis, which did not respond to multiple courses of antibiotics or prednisone. A panfungal polymerase chain reaction primer was positive for Saksenaea vasiformis, and she completed 5 months of oral posaconazole therapy after debridement. Saksenaea vasiformis is a rare cause of zygomycosis, and it typically causes skin and soft tissue infection in immunocompetent hosts, particularly after a traumatic injury. The diagnosis should be considered in cases with a protracted course that fail to respond to typical antibiotic therapy. Treatment includes surgical debridement, in additional to antifungal therapy with amphotericin B or posaconazole.

Publication types

  • Case Reports

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Child
  • Combined Modality Therapy
  • Debridement
  • Female
  • Humans
  • Immunocompetence
  • Mucorales / isolation & purification*
  • Mucormycosis / drug therapy*
  • Mucormycosis / immunology
  • Mucormycosis / microbiology*
  • Orbital Cellulitis / drug therapy*
  • Orbital Cellulitis / immunology
  • Orbital Cellulitis / microbiology*
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole